Rite-Aid (RAD) Feb Sales Fall Victim to Choppy Trends, Shift in Flu Season

March 7, 2013 1:22 PM EST Send to a Friend
Goldman Sachs today maintained a Neutral rating on Rite-Aid (NYSE: RAD) and raised its price target to $1.85 (from $1.70) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login